SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Clarksterh who wrote (1285)10/25/2004 11:46:30 AM
From: rjk01  Respond to of 1386
 
On Friday the comp placed a large “wanted” advertisement, among the listed are positions needed for expansion. Aviv will be presenting tomorrow (NY).



To: Clarksterh who wrote (1285)11/1/2004 11:32:04 AM
From: rjk01  Respond to of 1386
 
What the chance that Mrk or Pfizer will collaborate with pars? There is a thought that that Pars platform can benefit their current/x NSAID? I believe the company is planning to develop their own pain relief next year (PRS-311,375)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News